Cytodyn Inc (CYDY)

[stockorus]

Brazil was mentioned. The Einstein hospital there is supporting LL trial, are encouraged from our CD12, and people are working hard to get the process moving. Nader is projecting start date of July end (of course we can criticize that based on trackrecord; but it was mentioned clearly multiple times.)

For Philippines I agree he added nothing new and things may have stalled.

The main new thing about this CC is the great emphasis on bio-markers. Evidently they have found a lot of detailed information on how LL works and believe this can serve as quantifiable evidence on its mechanism and efficacy and from here can focus better on indications etc. Dr. Recknor sees this as very significant stuff.